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Abstract
Recent advances in molecular biology have made possible the identification of genetic defects
responsible for Wilson's disease, Indian childhood cirrhosis and copper toxicosis in Long Evans
Cinnamon rats, toxic milk mice, and Bedlington terriers. The Wilson's disease gene is localized on
human chromosome 13 and codes for ATP7B, a copper transporting P-type ATPase. A genetic
defect similar to that of Wilson's disease occurs in Long Evans Cinnamon rats and toxic milk mice.
Familial copper storage disorders in Bedlington and West Highland white terriers are associated
with early subclinical disease, and copper accumulation with subsequent liver injury culminating in
cirrhosis. The canine copper toxicosis locus in Bedlington terriers has been mapped to canine
chromosome region CFA 10q26. Recently, a mutated MURR1 gene was discovered in Bedlington
terriers affected with the disease. Idiopathic childhood cirrhosis is biochemically similar to copper
toxicosis in Bedlington terriers, but clinically much more severe. Both conditions are characterized
by the absence of neurologic damage and Kayser-Fleisher rings, and normal ceruloplasmin levels. A
recent study added North Ronaldsay sheep to the list of promising animal models to study Indian
childhood cirrhosis. Morphologic similarities between the two conditions include periportal to
panlobular copper retention and liver changes varying from active hepatitis to panlobular
pericellular fibrosis, and cirrhosis. Certain copper-associated disorders, such as chronic active
hepatitis in Doberman pinschers and Skye terrier hepatitis are characterized by copper retention
secondary to the underlying disease, thus resembling primary biliary cirrhosis in humans. Copper-
associated liver disease has increasingly being recognized in Dalmatians. Copper-associated liver
diseases in Dalmatians and Long Evans Cinnamom rats share many morphologic features. Fulminant
hepatic failure in Dalmatians is characterized by high serum activities of alanine aminotransferase
and aspartate aminotransferase, and severe necrosis of centrilobular areas (periacinar, zone 3)
hepatocytes. Macrophages and surviving hepatocytes contain copper-positive material. Liver
disease associated with periacinar copper accumulation has also been described in Siamese cats.
Many questions regarding copper metabolism in mammals, genetic background, pathogenesis and
treatment of copper-associated liver diseases remain to be answered. This review describes the
similarities between the clinico-pathological features of spontaneous copper-associated diseases in
humans and domestic animals.
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Introduction
Copper-associated diseases are increasingly being report-
ed in both man and animals [1–6]. Wilson's disease is an
autosomal recessive disorder that results from pathologi-
cal accumulation of copper predominantly in the liver
and brain [1]. Copper also has a role in fatal, non-Wil-
son's liver diseases affecting young children with a genetic
abnormality of copper metabolism [3,7]. Excess accumu-
lation of copper also occurs as a consequence of chronic
liver diseases such as primary biliary cirrhosis, and chron-
ic hepatitis in both humans [8] and animals [9]. A genetic
defect similar to that of Wilson's disease has been discov-
ered in the Long Evans Cinnamon (LEC) rat [10], and the
toxic milk mouse [11]. Animal models play an important
role in the study of copper homeostasis, mechanisms
(pathogenesis) of copper-associated liver diseases, and in
the implementation of new therapeutic approaches such
as gene therapy [12].
Copper homeostasis in mammals
The proximal small intestine is recognized as the main site
of dietary copper absorption in mammals [13]. Transport
from the intestinal lumen into intestinal mucosa is a car-
rier-mediated process involving a saturable transport
component [14]. The overall intestinal copper uptake is
influenced by amino acids, ascorbic acid, and other die-
tary factors [14]. Once in mucosal cells, approximately
80% of the newly absorbed copper is in the cytosol, main-
ly bound to metallothioneins (MT). These are low-molec-
ular weight inducible proteins with many functions
including homeostasis, storage, transport and detoxifica-
tion of metals [15,16]. Metallothioneins bind to many
metals, but in normal circumstances only Zn, Cu and Cd
binding is significant [17]. After passage through the ente-
rocytes, copper enters the portal circulation where it is
bound to carrier proteins (primarily albumin), peptides
and amino acids and is transported to the liver [18], with
lesser amounts entering the kidney [17].
Copper transport in hepatocytes can be divided into three
discernible but interrelated steps: copper uptake, intracel-
lular copper distribution and utilization, and copper ex-
port. At the hepatocellular cellular level copper uptake is
likely mediated by hCtr1, a copper transporter [19]. Up-
take of copper is competitively inhibited by divalent metal
ions such as cadmium, manganese, zinc, and cobalt [17].
Once within the hepatocyte, cytoplasmic copper chaper-
ones (hCOX17, HAH1/Atox1, hCCS) distribute the metal
to specific cellular compartments for its incorporation
into copper-requiring proteins. HAH1/Atox1 [20] may
function to bind copper and supply it to the Wilson's dis-
ease protein (ATP7B) in the trans-Golgi network. The
ATP7B gene encodes the Wilson's disease p-type ATPase
[21]. The ATP7B protein is required for incorporation of
copper into ceruloplasmin in the liver and for biliary ex-
cretion of copper [22–24]. ATP7B may also be involved in
the transport of copper to a vesicular compartment [25].
Copper from these vesicles may be delivered to lysosomes
[26]. Within hepatocytes, free copper would likely be tox-
ic to cells. However, it appears that copper is complexed
by reduced glutathione (GSH) soon after the metal enters
the cell [27]. The importance of GSH in metal detoxifica-
tion is supported by its role in the removal of toxic oxygen
species [28]. Following entry to the hepatocyte, in addi-
tion to GSH copper interacts with MT, and ceruloplasmin
[17]. The copper chaperone for MT has not been identi-
fied [27]. Copper is secreted into plasma as a complex
with ceruloplasmin [29,30]. This complex accounts for
90% to 95% of plasma copper [31]. In most mammals,
copper is excreted easily, and the main route of excretion
of copper is the bile [13,32]. Urinary copper excretion is
minimal under normal conditions since most of the cop-
per in circulating blood is bound to ceruloplasmin or con-
fined within the erythrocytes and very little copper crosses
the glomerular capillaries [14,33]. The process of hepato-
biliary copper secretion is still poorly understood. Two in-
dependent pathways have been identified for the
elimination of copper from hepatocytes into bile [34].
The first appears to be a vesicular pathway that involves
the delivery of lysosomal contents, including copper into
bile [32]. Reduction of copper excretion by microtubular
disruption from colchicine administration supports the
notion of a vesicular pathway [34]. A second pathway may
involve canalicular membrane transport of copper-glu-
tathione, and it functions when copper loads beyond
physiological levels are presented to liver cells [34]. Cop-
per transport into bile correlates well with the biliary ex-
cretion of glutathione [28], and the canalicular
multispecific organic anion transporter (cMOAT) may
contribute to biliary copper excretion [26], but the mech-
anism of normal biliary copper excretion is poorly
understood.
Disruption of the normal copper homeostasis or accumu-
lation of copper in excess of metabolic requirements can
lead to copper toxicity. Copper toxicosis can be classified
as primary when it results from an inherited metabolic de-
fect, and as secondary when it is the consequence of an ab-
normally high intake, increased absorption, or reduced
excretion of copper due to underlying pathologic
processes.
Spontaneous Copper toxicosis in humans and 
animals
Familial copper storage disorders occur in Wilson disease
in humans [35], LEC rats [36], toxic milk mouse [11,37],
Bedlington terriers [38,39], and in West Highland White
Terrier dogs [40]. Excess copper can accumulate within the
liver as a consequence of chronic cholestatic liver diseases
[8], particularly in diseases such as primary biliaryComparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
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cirrhosis [8,41], and chronic hepatitis [42]. Similar condi-
tions occur in certain breeds of dogs [5,9,43,44].
Wilson's disease
Wilson's disease is an autosomal recessive inherited disor-
der of copper metabolism [35,45,46]. Wilson's disease re-
sults in copper accumulation in the liver, cornea and brain
[1]. The worldwide incidence of Wilson's disease, inde-
pendent of ethnic and geographic origin, is approximately
1 in 30,000 [47]. However, it has been noted that the dis-
ease may be more common than previously expected, be-
cause most incidence estimations are based on adolescent
or adults presenting with neurologic symptoms, which oc-
cur only in about half of the patients [48]. The Wilson's
disease gene is localized on human chromosome 13 and
codes for ATP7B, a copper transporting P-type ATPase
[21]. The Wilson's disease mutations occur throughout
the whole gene and include missense and nonsense muta-
tions, deletions and insertions [49]. Most of the more
than 80 mutations are present at a low frequency, and mu-
tations differ between ethnic groups [50]. Thus, diagnosis
of Wilson's disease is challenging and requires a battery of
tests, including morphologic evaluation and copper anal-
ysis of liver tissue [51,52]. Liver disease may mimic vari-
ous forms of common liver conditions, ranging from
fulminant hepatic failure, chronic hepatitis, and cirrhosis
[1].
Animal models of Wilson's disease
The LEC rat [36] and the toxic milk mouse are the only
known valid animal models of Wilson's disease [11,37].
Animal models of Wilson's disease – LEC rat
The LEC rat with a hooded dilute agouti coat is a mutant
inbred strain, which was established from a closed colony
of randomly bred Long-Evans rats [36]. Long Evans Cin-
namon rats suffer from fulminant hepatitis and severe
jaundice at about 4 months of age and show similarities
to Wilson's disease in many clinical and biochemical fea-
tures [10,36]. This mutant has a deletion in the copper
transporting ATPase gene (Atp7b) homologous to the hu-
man Wilson's disease gene (ATP7B) [10,53], and the
mode of inheritance of hepatitis is also autosomal reces-
sive [54].
Similar to the condition in Wilson's disease, LEC rats
manifest elevated hepatic copper levels, defective incorpo-
ration of copper into ceruloplasmin, and reduced biliary
excretion of copper [55]. LEC rats develop intravascular
haemolysis secondary to the release of large amounts of
non-ceruloplasmin copper into the bloodstream [56], as
it has been described in patients with Wilson's disease
[14].
The hepatic copper concentration can rise to 2,126 ppm
dry weight [57]. It is also known that LEC rats may accu-
mulate as much iron as copper in the liver as a result of
hemolysis [56]. This mutant strain also possesses reduced
hepatic selenium [58]. Both accumulation of iron and de-
pletion of selenium in the liver may contribute to the de-
velopment of fulminant hepatitis, hepatic fibrosis, and
subsequent hepatocarcinogenesis in LEC rats by increas-
ing the process of oxidative damage with copper, and a re-
duction in the antioxidant capacity against copper-
induced free-radical damage [56,58].
It has been suggested that an immune-mediated mecha-
nism may play a role in the development of acute lethal
hepatitis in LEC rats. Autoimmune antibodies to liver mi-
crosomal proteins have been demonstrated 3–7 weeks be-
fore death in these rats [59]. Protein disulfide isomerase
and calreticulin have been identified as antigens in liver
microsomes of this mutant [60], and treatment with im-
munosuppressant drugs such as cyclosporin-A reduced
the mortality in LEC rats [61]. However, a recent study
showed that the development of antimicrosomal antibod-
ies does not precede the development of severe liver dam-
age in the LEC rat model [62].
The clinical signs of hepatitis include severe jaundice, a
bleeding tendency, oliguria, lethargy, and loss of body
weight. During this period, activities of serum enzymes,
lactate dehydrogenase (LDH), alanine aminotransferase
(ALT) [63], aspartate aminotransferase (AST), and γ-
glutamyltransferase (GGT), as well as bilirubin levels, are
increased significantly [36,54,62]. While the serum levels
of ceruloplasmin remain reduced all the time [60], the
copper concentration in serum increases mainly after the
onset of jaundice [63]. About half of the animals die with-
in a week of the onset of jaundice [36].
Histological changes of acute hepatitis in LEC rats occur
prior to 8 weeks of age, and the most drastic changes occur
from 17 to 20 weeks of age [36]. A recent study utilizing
female LEC rats reports biochemical and morphological
evidence of severe liver damage at 12 weeks of age [62].
Histological changes are characterized by hepatocellular
karyomegaly, large numbers of Councilman bodies, sub-
massive necrosis [54], mitosis of hepatocytes [36], and ap-
optosis [56]. After this stage, surviving rats develop
chronic hepatitis, cholangiofibrosis, preneoplastic foci
and nodules, and hepatocellular carcinomas [46,54,56].
Histochemical examination of LEC rat liver for copper re-
veals that copper accumulates preferentially in hepato-
cytes and distributes diffusely throughout the cytoplasm.
Copper accumulates in virtually all hepatocytes through-
out the entire liver lobule, but shows a tendency to local-
ize in the periportal areas [64]. LEC rats that survive the
stage of fulminant hepatitis develop cirrhosis [65], andComparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
Page 4 of 12
(page number not for citation purposes)
are highly susceptible to the development of hepatocellu-
lar carcinoma [64]. This is an interesting feature of this
particular animal model because hepatocellular carcino-
ma is rarely diagnosed in Wilson's disease patients [66].
Animal models of Wilson's disease – Toxic milk mice
Toxic milk is an autosomal recessive mutation which al-
ters copper homeostasis in mice [37]. Offspring of mutant
females are born copper-deficient and since their mother's
milk is also low in copper, babies die at 2 weeks of age.
The progeny of affected dams fostered to lactating normal
females survive but with age copper accumulate in their
livers [67]. By 6 months of age, liver changes are character-
ized by nodular fibrosis, bile duct hyperplasia and portal
lymphocytic inflammatory cell infiltration [67]. Toxic
milk mice share some biochemical abnormalities with
Wilson's disease for example concentration of serum cop-
per and ceruloplasmin are decreased. The genetic defect in
toxic milk mice is similar to that of Wilson's disease [11].
Although gross and histologic changes in the liver in both
rodent models (i.e. LEC rat and toxic milk mice) resemble
Wilson's disease [67], same differences have been noted.
Neither of the rodent models has neurologic symptoms,
and in the toxic milk mice model affected dams produce
Cu-deficient milk, whereas there are no reports of Cu-de-
ficient milk in humans mothers with Wilson's disease
[68].
Indian childhood cirrhosis
Indian childhood cirrhosis and its analogues endemic Ty-
rolean infantile cirrhosis, and idiopathic copper toxicosis,
are fatal liver diseases seen in young children due to genet-
ic susceptibility to minimal excess in dietary copper [2–
4,7]. The gene for Indian childhood cirrhosis diagnosed in
North America has recently been identified [69].
North Ronaldsay sheep
This primitive breed has adapted to copper impoverished
environment and display an abnormal sensitivity to cop-
per toxicity when transferred to copper adequate location
[70]. A recent study reports the remarkable similarities be-
tween the condition in North Ronaldsay sheep and Indian
childhood cirrhosis, whereby affected sheep exhibited liv-
er changes varying from active hepatitis to panlobular
pericellular fibrosis, and cirrhosis. Histochemical stains
demonstrated periportal to panlobular histochemical
copper retention [6].
Primary biliary cirrhosis
Primary biliary cirrhosis is a chronic progressive, often fa-
tal liver disease, characterized by the eventual develop-
ment of cirrhosis and liver failure [31,41]. Middle-aged
females are predisposed to the condition [71]. The immu-
nological abnormalities and morphologic features ob-
served in primary biliary cirrhosis, favour the hypothesis
of an immune-mediated mechanism [72,73]. However,
the nature of the initiating factor(s) and of the sensitizing
antigen is unknown. The only effective treatment for this
disease is liver transplantation [74]. Indeed, primary bil-
iary cirrhosis is one of the five most frequent causes of liv-
er transplantation [75]. Although copper accumulation is
a secondary event [76], therapeutic approaches have in-
cluded attempts to remove excess hepatic copper in order
to avoid possible synergism between the initiating fac-
tor(s) and release of copper into the liver [77].
Animal models of primary biliary cirrhosis
Certain disorders, such as chronic active hepatitis in Do-
berman pinschers and Skye terrier hepatitis are character-
ized by copper retention secondary to the underlying
disease, thus resembling primary biliary cirrhosis in hu-
mans [44]. Copper values are never so elevated as in the
familial storage diseases.
Animal models of primary biliary cirrhosis – Chronic hepa-
titis in Doberman Pinschers
Doberman hepatitis is a disorder associated with histolog-
ic features of chronic active hepatitis, cholestasis, and cir-
rhosis. Middle aged, spayed female dogs are predisposed
to the disease [9,43,78]. The cause of the disease remains
undetermined, but histopathological changes support the
idea of immune-mediated disorder [79]. Copper accumu-
lates in centroacinar (portal) areas [9,80]. The present
knowledge on the role of copper in this disorder is incom-
plete; however, the presence of copper in liver biopsies
constitutes one of the essential diagnostic criteria for sub-
clinical Doberman hepatitis [80].
Animal models of primary biliary cirrhosis – Skye terrier 
hepatitis
This condition appears to be an unusual lesion character-
ized by intracanalicular cholestasis, with copper accumu-
lation and hepatocellular degeneration culminating in
cirrhosis [44]. Copper accumulation occurs primarily in
the periacinar area, which is inconsistent with other disor-
ders associated with cholestasis and subsequent tissue
copper retention [81]. The cause is unknown, but an in-
heritable metabolic defect involving membrane transfer
and transport systems in the periacinar zone, resulting in
disturbed bile secretion and excessive copper accumula-
tion have been suggested [44].
Animal models of primary biliary cirrhosis – Feline cholan-
giohepatitis complex
This condition has three well-characterized histopatho-
logic lesions, but the etiology and pathogenesis of the
condition is poorly understood [82]. The non-suppurative
type has been compared to primary biliary cirrhosis in hu-
mans [83,84]. Non-suppurative cholangitis in cats is char-
acterized by lymphocytic and plasmacytic portalComparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
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infiltration, bile duct hyperplasia, and portal fibrosis. His-
tochemical stains demonstrate copper positive granules
within portal hepatocytes (ICF personal observation). The
value of this model in the study of primary biliary cirrho-
sis has not been thoroughly assessed.
Other copper associated disease in dogs
In general, naturally occurring canine genetic diseases re-
semble human diseases more faithfully than their rodent
counterpart, as there is a higher degree of DNA sequence
identity between humans and dogs than between humans
and rodents [85]. Familial copper storage disorders in Be-
dlington and West Highland white terriers are usually as-
sociated with early subclinical disease during which
copper accumulates with subsequent liver injury culmi-
nating in cirrhosis [40,86]. Occasionally however, there
may be a copper-induced hemolytic crisis in Bedlington
terriers [86,87]. Bedlington Terrier copper toxicosis has
generated much interest as a possible animal model for
Wilson's disease. However, it has been proven that Wil-
son's disease and Bedlington Terrier copper toxicosis do
not share the same genetic defect [88]. The canine copper
toxicosis locus in Bedlington terriers has been mapped to
canine chromosome region CFA 10q26 [88] and in addi-
tion to ATPB, ATOX 1 [89,90], ATP6H [91] have been ex-
cluded as candidate genes underlying copper toxicosis in
Bedlington terriers [89,90]. Recently, a mutated MURR1
gene was discovered in Bedlington terriers affected with
the disease [85].
Some similarities have been noted between Bedlington
terriers and idiopathic childhood cirrhosis. Idiopathic
childhood cirrhosis is biochemically similar to copper
toxicosis in Bedlington terriers [85], but clinically much
more severe [7]. Both conditions are characterized by the
absence of neurologic damage and Kayser-Fleisher rings
[92,93], and normal ceruloplasmin levels [47].
Liver copper values can be as high as 12,000 ppm dry
weight in Bedlington terriers [94] whereas the highest
copper value recorded in West Highland white terriers is
6,800 ppm dry weight [95]. In Bedlington terriers older
than 1 year of age, there is a progressive increase in the ac-
cumulation of tissue copper until 8 years of age [81].
There is no relationship between age, histomorphological
changes and hepatic copper concentration in West High-
land white terriers. The clinical signs vary widely, depend-
ing on the stage of the disease. Affected animals in the
early stages usually are asymptomatic. Depression, ano-
rexia, lethargy, vomiting, and increased ALT are usually as-
sociated with an acute onset of hepatic necrosis.
Microscopically, there is a spectrum of recognizable
changes. In the least affected or subclinical cases, accumu-
lation of intracytoplasmic refractile, light-brown granules
in vacuolated parenchymal cells of the periacinar zones
are observed which stain histochemically positive for cop-
per. This is followed by the development of foci of hepa-
tocellular degeneration and necrosis with scattered
inflammatory response of neutrophils, lymphocytes and
plasma cells. Fine fibrous septa extend from the portal ar-
eas into the lobules. More advanced stages are character-
ized by periportal infiltrates of inflammatory cells and
prominent piecemeal necrosis (resembling chronic active
hepatitis). Piecemeal necrosis has not been described in
West Highland white terriers toxicosis. Finally, there is a
complete architectural disorganization of the liver with
variable sized nodules of hepatocytes (with focal degener-
ation and aggregates of neutrophils) separated by bands
of fibrous connective tissue with portal-central bridging
[94,96]. Contrary to Wilson's disease, hepatocytes with
Mallory bodies have not been identified [97].
Copper-associated liver disease has increasingly being rec-
ognized in Dalmatians [98,99] (Figs. 1,2). Fulminant he-
patic failure characterized by high serum activities of ALT
and AST. Histologically, there is severe necrosis of hepato-
cytes involving the centrilobular areas. Macrophages and
surviving hepatocytes contain copper-positive material
[98]. Primary copper storage disease was suspected on the
basis of histologic findings and high copper concentration
in the liver [99]. Morphologic changes observed in Dal-
matians are strikingly similar to those observed in LEC
rats (ICF personal observation) suggesting that copper
toxicosis in Dalmatians is a promising spontaneous ani-
mal model of Wilson's disease.
Excess copper accumulation occurs as a consequence of
chronic liver disease in other canine breeds dogs
[5,9,43,44], particularly Cocker Spaniels and Poodles [9].
Similarly, secondary copper accumulation has been de-
scribed in chronic hepatitis in humans [42].
Spontaneous copper-associated liver disease in other 
mammalian species
Sheep are particularly susceptible to copper poisoning
[100,101]. The condition occurs when sheep are acciden-
tally fed rations prepared for other species (i.e. bovine or
swine) [100,102]. Copper poisoning in sheep is common-
ly diagnosed. In contrast, copper toxicosis in other farm
animals is rarely reported [103].
Spontaneous copper-associated liver disease in other 
mammalian species – Copper toxicosis in sheep
Chronic copper poisoning in sheep results from the accu-
mulation of copper in hepatic tissue over a period of a few
weeks to more than a year [100,101], and is considered to
have two distinct phases [104]. During the accumulation
or pre-hemolytic phase, animals may be clinically normal,
even with liver copper concentrations of 1,000 ppm, so
long as increasing mitotic rate produces enough newComparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
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hepatocytes to take up the copper released by dying cells
[94]. However, liver damage does occur during this period
as indicated by increased levels of lactic dehydrogenase
and AST [100]. The second phase, or hemolytic crisis, lasts
from hours to days and is characterized by the sudden on-
set of severe intravascular hemolysis and hemoglobine-
mia associated with increased blood copper levels, with
resulting liver [104,105], kidney, and brain damage [106].
During the hemolytic phase, elevated serum values of
AST, GGT, ALP, copper, urea nitrogen (BUN), bilirubin
[100,107], and ceruloplasmin [108] have been observed.
Elevation of blood copper occurs prior to and during the
hemolysis; the ceruloplasmin levels tend to fluctuate but
in most instances there is a two-fold or more increase im-
mediately before and during the hemolytic crisis [108].
The histologic changes are present in the liver in the pre-
clinical stages and can be somewhat obscured by the peri-
acinar (centrilobular) necrosis of hypoxemia and the bile
accumulations of hemolytic disease [94]. Copper can be
demonstrated histochemically with rubeanic acid or
rhodanine as fine granules within the cytoplasm of paren-
chymal and Kupffer cells [104,108]. Copper in hepato-
cytes is mostly located within lysosomes [109]. It has been
demonstrated that copper deposition begins in the periac-
inar areas extending to the mid and periportal zones with
progressive copper-loading [109].
Spontaneous copper-associated liver disease in other 
mammalian species – Copper-associated liver disease in 
cats
Liver disease associated with centrilobular (periacinar,
zone 3) copper accumulation was described in a Siamese
cat [110]. One of the authors (ICF) has examined cases of
copper-associated liver disease in cats, with morphologic
characteristics similar to those reported in Siamese cats
Figure 1
Dalmatian dog liver. Dissecting hepatitis with marked mononuclear inflammation. P = portal. HE stain. Bar = 50 µm.Comparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
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(Figs. 3,4), suggesting that metabolic defects of copper
metabolism occur with relative frequency in the feline
specie and may have been overlooked in the past.
Spontaneous copper-associated liver disease in other 
mammalian species – Copper-associated liver disease in 
ferrets
Two cases have been described in ferrets [111]. One case
was characterized by chronic hepatopathy, with diffuse
hepatocellular vacuolation, and the second case had cen-
trilobular degeneration and necrosis. In both ferrets, liver
copper concentration was markedly elevated and special
staining revealed copper pigment in hepatocytes and mac-
rophages. An inherited defect of copper metabolism was
suspected in these ferrets based on the lack of related ill-
ness in 11 other ferrets housed in the same environment
and receiving the same diet.
Treatment of Cu-associated disease in animal 
models
D-penicillamine has been effective in the treatment of Be-
dlington Terrier toxicosis [81]. However, copper is only
slowly removed from the liver and clinical improvement
generally requires years of treatment [112]. Side effects
seen with D-penicillamine therapy in humans include fe-
ver, anorexia, pyridoxine deficiency, leukopenia, throm-
bocytopenia [113,114], rashes and proteinuria [47]. In
dogs, treatment with D-penicillamine often is associated
with anorexia, nausea and vomiting [92,112,115].
Alternate agents such as trientine [116], tetrathiomolyb-
date (TTM) [117,118], and zinc [119,120] have been em-
ployed in the treatment of Wilson's disease. Zinc [121]
have been used for the treatment of copper toxicosis in
sheep and dogs [119]. In sheep, ammonium tetrathiomo-
lybdate lowers liver concentrations and prevents the de-
Figure 2
Dalmatian dog liver. Prominent copper-positive granules. P = Portal. Rhodanine stain. Bar = 50 µm.Comparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
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velopment of hemolysis, however, the kidneys
accumulate large amounts of copper [122,123]. It also ap-
pears that TTM is not fully excreted after treatment but
molybdenum is widely distributed and retained in many
organs including brain and pituitary [124].
Conclusions
Recent advances in molecular biology have made possible
the identification of genetic defects responsible for Wil-
son's disease, Indian childhood cirrhosis, and copper tox-
icosis in LEC rats, toxic milk mice, and Bedlington terriers.
However, many questions regarding copper metabolism
in mammals, and pathogenesis and treatment of copper-
associated liver diseases remain to be answered. Studies
designed to identify genetic defects of copper metabolism
and to implement new therapeutic approaches to cure
these conditions will greatly contribute to the knowledge
of the pathogenesis of copper-associated diseases. This re-
view demonstrates that there are numerous spontaneous
animal models of copper-associated liver diseases. Based
on the clinical presentation and morphological features,
copper-associated liver disease in Dalmatians dogs has the
potential to be a good model of Wilson's disease. North
Ronaldsay sheep is a promising model to study Indian
Childhood cirrhosis and its analogues, and Bedlington
Terrier copper toxicosis may share many similarities with
Indian childhood cirrhosis. In the future, increased re-
search collaboration between basic and applied scientists
will be needed to link molecular defects to their morpho-
logic and clinical implications.
Methods
The following methods are routinely used in our labora-
tory for qualitative and quantitative detection of copper.
Figure 3
Liver from a cat with severe hepatic lipidosis. Diffuse severe hepatocellular vacuolation. P = Portal. HE stain. Bar = 50 µm.Comparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
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Rhodanine method for histochemical detection of copper
Liver sections are dewaxed and hydrated to distilled water.
Then, sections are placed in rhodanine working solution
at 37°C for 18 hours. Rhodanine working solution is pre-
pared using 3.0 ml of 0.2% Rhodanine stock solution (0.2
g rhodanine in 100 ml 100% ethanol) and 50 ml buffer
acetate (5.0 ml 40% formalin, 20 g sodium acetate in
1000 ml distilled water).
Slides are rinsed in 3 changes of acetate buffer solution,
counterstained in Mayer's hematoxylin solution, rinsed in
acetate buffer, dehydrated, cleared and mounted.
Measurement of copper in tissue by flame atomic absorp-
tion spectroscopy
Liver samples are placed in plastic bags, frozen at -80°C
and stored for 24 hours. Tissues are then processed for
atomic absorption spectrophotometry. Briefly, approxi-
mately 1 gram of tissue from each sample is weighed and
placed in a Teflon container for microwave digestion. All
samples are weighed in duplicate. Control samples with
known amounts of copper are also included. To each ves-
sel, including a blank containing no tissue, 1.0 ml of
deionized, distilled water and 2.5 ml full strength, trace
metal free nitric acid (10.95 M HNO3) is added. Vessels
are capped and placed in a MDS-200 microwave oven and
digested. The digested contents are poured off and diluted
to 10 ml with distilled water and thoroughly mixed. Cop-
per concentrations are measured using a spectrophometer
equipped with a copper hollow cathode lamp, with the
following instrument settings: wavelength 324.8 nm, slit
width 0.7 nm, lamp current 17 mA. Standards used are 3,
6 and 12 ppm prepared from 1000 ppm stock standard in
0.2 M HNO3. Peak area is read with a read delay of 0 s,
and a read time of 5 s. Standard reference materials are
used as quality control substances, and are processed with
Figure 4
Liver from a cat with severe hepatic lipidosis. Prominent copper-positive granules. P = Portal. Rhodanine stain. Bar = 50 µm.Comparative Hepatology 2003, 2 http://www.comparative-hepatology.com/content/2/1/5
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each batch of liver samples. Samples are not corrected for
recovery if the he recovery of the quality control samples
is 95% or more. Cu concentrations are recorded in µg/g
wet weight tissue.
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